Veronica Yioe

P254 Home spirometry monitoring as an adjunct to clinical care in patients with fibrotic interstitial lung diseases: findings from the REMOTE-ILD randomised controlled trial

Stefanie Barth, Rebecca Borton, Colin C. Edwards, Elena Pizzo et autres

Introduction Remote monitoring of lung function has been proposed as an adjunct to support clinical care in patients with interstitial lung diseases (ILD). Previous studies have shown that home spirometry correlates well with hospital measurements and that patients are willing to do …

gb (code pays fourni par la source)

P25 Impact of tiered service delivery model on antifibrotic adherence and mortality among patients with interstitial lung disease

Fred Fyles, Alastair D. McKinnon, Sarah Agnew, Jonathan Sutcliffe et autres

Introduction Regional models of care using shared care and tiered delivery may tackle health inequalities for patients with interstitial lung disease (ILD) and provide high-standard care closer to home [ILD Care Pathway, One Voice ILD, April 2024]. The Merseyside ILD network have …

gb (code pays fourni par la source)

Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review

Koushan Kouranloo, Mrinalini Dey, Helen Elwell, Veronica Yioe et autres

OBJECTIVES: Anti-synthetase syndrome (ASS) is a chronic autoimmune condition, with interstitial lung disease (ILD) being a key feature. This systematic literature review (SLR; CRD42023416414) aimed to summarize treatments and outcomes of ILD associated with ASS (ASS-ILD). METHODS: Databases were searched for articles …

gb, us (code pays fourni par la source)

The Prevalence and Clinical Significance of Eosinophilia in Bronchoalveolar Lavage Fluid in Patients With Interstitial Lung Disease

Kirsty Bowes, Jeannie Callum, Veronica Yioe, Stefan Cristian Stanel et autres

gb (code pays fourni par la source)

Impact of Instilled Saline Volume on Adequate Bronchoalveolar Lavage Sample in Interstitial Lung Disease Diagnosis

Jeannie Callum, K.S.P. Bowes, James Duncan Johnston, Veronica Yioe et autres

gb (code pays fourni par la source)

Real world incidence & prevalence of PF-ILD in a systemic sclerosis cohort

Rosalind Benson, Mahin Ahmad, Theresa C. Barnes, Madhusudan Paravasthu et autres

Background Systemic sclerosis related interstitial lung disease (SSc-ILD) causes significant morbidity/mortality. Early diagnosis & treatment with immunosuppression can improve outcome. Some progress to a more fibrotic phenotype (progressive fibrotic ILD: PF-ILD) associated with worsening of variable combination of symptoms/imaging/pulmonary function tests. A …

gb (code pays fourni par la source)

Interstitial lung disease on the acute take for the non-respiratory physician

Veronica Yioe, Gerrard Phillips, Lisa G. Spencer

Interstitial lung diseases (ILDs) are a heterogeneous group of diseases characterised by varying degrees of fibrotic and/or inflammatory abnormalities of the lung parenchyma. Management of ILD is often challenging for non-respiratory physicians. We discuss the respiratory assessment and management of patients with …

gb (code pays fourni par la source)

Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service

Rebecca C. Robey, Katie Kemp, Philip Hayton, Dalia Mudawi et autres

At the end of the first year of the COVID-19 pandemic, more than 78 million known survivors were recorded. The long-term pulmonary sequelae of COVID-19 remain unknown. We performed a retrospective analysis of a post-COVID follow-up service to estimate the burden of …

gb (code pays fourni par la source)

P168 Patient symptoms following discharge from hospital after COVID-19 Pneumonia

Laurence Pearmain, Cristina Avram, Veronica Yioe, Penelope M. Webb et autres

Introduction The recovery of patients after COVID-19 has been poorly described. Related coronavirus infections (SARS-COV1 and MERS) have protracted recovery time-courses with significant respiratory morbidity,1 suggesting the same may be true for COVID-19. A service evaluation was therefore undertaken to evaluate the …

gb (code pays fourni par la source)

Patient symptoms following discharge from hospital after COVID-19 pneumonia

Laurence Pearmain, Cristina Avram, Veronica Yioe, P Webb et autres

Introduction The recovery of patients after COVID-19 has been poorly described Related coronavirus infections (SARSCOV1 and MERS) have protracted recovery time-courses with significant respiratory morbidity,1 suggesting the same may be true for COVID-19 A service evaluation was therefore undertaken to evaluate the …

Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases

Kevin James Munro, Kai Uus, Ibrahim Almufarrij, Nazia Chaudhuri et autres

Dear EditorWhile the pace of research on the novel coronavirus, SARS-CoV-2, has been impressively rapid, there remains a lot we still do not know about the pathogen. One of those unknowns is the po...

gb (code pays fourni par la source)

Self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases

Kevin James Munro, Kai Uus, Ibrahim Almufarrij, Nazia Chaudhuri et autres